Modern strategies for the treatment of type 2 diabetes in patients with stable coronary artery disease. Old goals, new opportunities (literature review)

Q3 Medicine

Russian Journal of Cardiology Pub Date : 2024-01-15 DOI:10.15829/1560-4071-2024-5689

S. L. Grishaev, D. V. Cherkashin, V. Salukhov, A. E. Alanichev

引用次数: 0

Abstract

The review summarizes and analyzes the available literature to provide information to clinicians about the best treatment strategies for type 2 diabetes in stable coronary artery disease. This data should help health care professionals make decisions in routine practice. 2023 European and Russian guidelines on type 2 diabetes suggest giving preference to glucose-lowering agents with proven benefits for the cardiovascular system, followed by drugs with proven safety for the cardiovascular system.

查看原文本刊更多论文

治疗冠心病稳定期患者 2 型糖尿病的现代策略。旧目标，新机遇（文献综述）

这篇综述总结并分析了现有文献，为临床医生提供了有关冠心病稳定期 2 型糖尿病最佳治疗策略的信息。这些数据应有助于医护人员在日常工作中做出决定。2023 年欧洲和俄罗斯的 2 型糖尿病指南建议优先选择经证实对心血管系统有益的降糖药物，其次是经证实对心血管系统安全的药物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Russian Journal of Cardiology Medicine-Cardiology and Cardiovascular Medicine

CiteScore

2.20

自引率

0.00%

发文量

185

审稿时长

1 months

期刊介绍： Russian Journal of Cardiology has been issued since 1996. The language of this publication is Russian, with tables of contents and abstracts of all articles presented in English as well. Editor-in-Chief: Prof. Eugene V.Shlyakhto, President of the Russian Society of Cardiology. The aim of the journal is both scientific and practical, also with referring to organizing matters of the Society. The best of all cardiologic research in Russia is submitted to the Journal. Moreover, it contains useful tips and clinical examples for practicing cardiologists. Journal is peer-reviewed, with multi-stage editing. The editorial board is presented by the leading cardiologists from different cities of Russia.